Cause of death, by non-communicable diseases, ages 5-14, male in Africa Eastern and Southern
Africa Eastern and Southern: Cause of death, by non-communicable diseases, ages 5-14, male was 17.3% in 2021. ▲ Rising
Cause of death, by non-communicable diseases, ages 5-14, male in Africa Eastern and Southern, 2000–2021
Source: Global Health Estimates, World Health Organization (WHO). Measured in % of total male deaths ages 5-14.
Analysis
Africa Eastern and Southern recorded 17.3% for cause of death, by non-communicable diseases, ages 5-14, male in 2021.
Compared with earlier readings it is down 0.1% on the previous year and up 35.1% over ten years.
Over the whole period, cause of death, by non-communicable diseases, ages 5-14, male in Africa Eastern and Southern peaked at 17.4% in 2020 and was at its lowest, 11.2%, in 2000.
Africa Eastern and Southern ranks 47th of 47 groups on this measure, in the bottom quarter.
Cause of death, by non-communicable diseases, ages 5-14, male in Africa Eastern and Southern, year by year
| Year | % of total male deaths ages 5-14 | Change |
|---|---|---|
| 2000 | 11.2% | — |
| 2010 | 12.8% | +14.6% |
| 2015 | 14.5% | +12.8% |
| 2019 | 17.2% | +19.1% |
| 2020 | 17.4% | +0.7% |
| 2021 | 17.3% | -0.1% |
Averages by decade
| Decade | Average | Lowest | Highest | Years |
|---|---|---|---|---|
| 2000s | 11.2% | 11.2% | 11.2% | 1 |
| 2010s | 14.8% | 12.8% | 17.2% | 3 |
| 2020s | 17.3% | 17.3% | 17.4% | 2 |
Countries ranked near Africa Eastern and Southern
More health data for Africa Eastern and Southern
- Population ages 05-09, male, per unit of GDP 0 units per US$ of GDP (2025)
- Population ages 45-49, male, per unit of GDP 0 units per US$ of GDP (2025)
- Population ages 65 and above, female, per unit of GDP 0 units per US$ of GDP (2025)
- Population ages 45-49, male, annual growth rate 4.21 % change on previous year (2025)
- Population ages 45-49, female, per capita 0.0196 units per person (2025)
- Population ages 45-49, female, per unit of GDP 0 units per US$ of GDP (2025)
- Population ages 45-49, female, annual growth rate 3.96 % change on previous year (2025)
- Population ages 40-44, male, per capita 0.0232 units per person (2025)
- Population ages 40-44, male, per unit of GDP 0 units per US$ of GDP (2025)
- Population ages 35-39, male, per capita 0.0284 units per person (2025)
Frequently asked questions
- What is cause of death, by non-communicable diseases, ages 5-14, male in Africa Eastern and Southern?
- Cause of death, by non-communicable diseases, ages 5-14, male in Africa Eastern and Southern was 17.3% in 2021, according to Global Health Estimates, World Health Organization (WHO).
- What is the highest cause of death, by non-communicable diseases, ages 5-14, male recorded in Africa Eastern and Southern?
- The highest recorded value was 17.4% in 2020.
- What is the lowest cause of death, by non-communicable diseases, ages 5-14, male recorded in Africa Eastern and Southern?
- The lowest recorded value was 11.2% in 2000.
- How does Africa Eastern and Southern rank for cause of death, by non-communicable diseases, ages 5-14, male?
- Africa Eastern and Southern ranks 47th out of 47 groups with data for 2021.
- Is cause of death, by non-communicable diseases, ages 5-14, male rising or falling in Africa Eastern and Southern?
- Over the last ten years it is up 35.1%. The long-run trend across the full record is rising.
- Where does this Africa Eastern and Southern data come from?
- The figures come from Global Health Estimates, World Health Organization (WHO), published as part of Cause of death, by non-communicable diseases, ages 5-14, male (% of total male deaths ages 5-14). Statizoid updates them automatically from the source API.
Download this data
CSV · JSON — 6 observations, free to reuse under CC BY 4.0 (World Bank Open Data).
About this data
Number of male deaths ages 5-14 due to non-communicable diseases divided by number of all male deaths ages 5-14, expressed by percentage. Non-Communicable diseases include cancer, diabetes mellitus, cardiovascular diseases, digestive diseases, skin diseases, musculoskeletal diseases, and congenital anomalies.